Post-Market Safety Registries
Safety monitoring registries tracking long-term outcomes and adverse events after psychedelic therapy in real-world clinical settings.
All Organisations
America's Poison Centers
US network of poison centers and national data system (NPDS) for toxicology and pharmacovigilance surveillance.
Citeline
Citeline (formerly Informa Pharma Intelligence) is a global pharmaceutical data and clinical intelligence platform providing AI-driven drug pipeline tracking, trial monitoring, and R&D analytics to life sciences organisations. It is referenced as a data source in the Department of Defense PTSD Adaptive Platform Trial involving SLS-002 (esketamine intranasal spray).
EMA EudraVigilance
European pharmacovigilance system for suspected adverse drug reaction reporting. Psychedelic relevance: EMA has hosted a multi-stakeholder psychedelics regulatory workshop and EudraVigilance is the key EU safety channel.
FDA Adverse Event Monitoring System (AEMS)
US FDA adverse-event monitoring infrastructure for regulated products. Psychedelic relevance: FDA has issued draft clinical trial guidance for psychedelic drugs and AEMS is the active public safety-monitoring surface.
FDA MedWatch
US FDA adverse-event and product-problem reporting program with public safety communications and reporting channels.
Health Canada Canada Vigilance
National adverse reaction reporting and access database for marketed health products in Canada. Psychedelic relevance: Health Canada publishes psilocybin-specific clinical-trial and special-access policy notices.
MHRA Yellow Card
UK safety reporting program for medicine and device adverse events. Psychedelic relevance: UK has active policy and trial activity, while public MHRA records indicate no authorized psilocybin medicinal product yet.
Medsafe & CARM Pharmacovigilance
New Zealand pharmacovigilance infrastructure operated through Medsafe and CARM for adverse-reaction reporting, analysis, and signal monitoring. Public psychedelic-specific dashboards are limited; this profile is included as core safety infrastructure.
Netherlands Pharmacovigilance Centre Lareb
National pharmacovigilance centre for the Netherlands supporting adverse drug reaction reporting, signal detection, and patient-reporting channels. Public psychedelic-specific evidence views are limited; this profile is included as core safety infrastructure.
Rocky Mountain Poison & Drug Safety
US poison center and toxicology surveillance organization supporting data collection and safety monitoring operations.
Singapore HSA Adverse Event Reporting
Singapore Health Sciences Authority adverse-event reporting framework for therapeutic products and clinical trials. Included as core safety-monitoring infrastructure; no dedicated psychedelic public reporting surface identified.
Swissmedic ElViS
Swissmedic electronic vigilance infrastructure for adverse drug reaction reporting by healthcare professionals and companies in Switzerland. Included as core safety infrastructure; psychedelic-specific public slices are limited.
TGA DAEN
Australian adverse-event notification database and safety-monitoring framework. Psychedelic relevance: TGA publishes dedicated policy and access guidance for MDMA and psilocybin use.
Uppsala Monitoring Centre
WHO collaborating centre for international drug safety monitoring, stewarding VigiBase and global pharmacovigilance methods.